Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity)
- PMID: 16817829
- DOI: 10.1111/j.1365-2265.2006.02558.x
Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity)
Abstract
Objective: To quantify body adiposity and its distribution in untreated adult patients with Laron syndrome (LS; primary GH insensitivity) caused by molecular defects of the GH receptor gene or postreceptor pathways and characterized by dwarfism, obesity, insulin resistance and hyperlipidaemia.
Patients: Eleven LS patients (seven females and four males) aged 28-53 years were studied. Seven healthy males and six healthy females served as controls.
Measurements: Body composition of the total body trunk, upper and lower extremities was determined using dual-energy X-ray absorptiometry (DEXA). Statistical analysis using an analysis of variance (anova) and Mann-Whitney nonparametric methods was performed separately in males and females.
Results: Percentage body fat in the LS patients was much higher (P < 0.01) than that in the control population and the female LS patients were significantly more obese (59% total body fat) than the male patients (39% total body fat) (P < 0.002). It was also evident that in these types of patients with markedly increased body fat and decreased muscle and bone mass, body mass index (BMI) does not accurately reflect the body composition.
Conclusions: Lifelong congenital IGF-I deficiency leads to extreme adiposity.
Similar articles
-
Long-term IGF-I treatment of children with Laron syndrome increases adiposity.Growth Horm IGF Res. 2006 Feb;16(1):61-4. doi: 10.1016/j.ghir.2005.12.001. Epub 2006 Jan 27. Growth Horm IGF Res. 2006. PMID: 16442822
-
Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?Clin Endocrinol (Oxf). 2006 Dec;65(6):783-91. doi: 10.1111/j.1365-2265.2006.02667.x. Clin Endocrinol (Oxf). 2006. PMID: 17121531
-
IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.Growth Horm IGF Res. 2009 Jun;19(3):280-2. doi: 10.1016/j.ghir.2008.11.004. Epub 2008 Dec 30. Growth Horm IGF Res. 2009. PMID: 19117781
-
Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:188-91. Pediatr Endocrinol Rev. 2006. PMID: 16641857 Review.
-
Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.Growth Horm IGF Res. 2012 Apr;22(2):49-52. doi: 10.1016/j.ghir.2012.02.005. Epub 2012 Mar 11. Growth Horm IGF Res. 2012. PMID: 22414926 Review.
Cited by
-
Altered structure and function of adipose tissue in long-lived mice with growth hormone-related mutations.Adipocyte. 2017 Apr 3;6(2):69-75. doi: 10.1080/21623945.2017.1308990. Epub 2017 Mar 21. Adipocyte. 2017. PMID: 28425851 Free PMC article. Review.
-
The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies.Clin Proteomics. 2017 Jun 29;14:24. doi: 10.1186/s12014-017-9160-2. eCollection 2017. Clin Proteomics. 2017. PMID: 28670222 Free PMC article. Review.
-
The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice.Mol Endocrinol. 2013 Mar;27(3):524-35. doi: 10.1210/me.2012-1330. Epub 2013 Jan 24. Mol Endocrinol. 2013. PMID: 23349524 Free PMC article.
-
The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate.J Biol Chem. 2010 Feb 12;285(7):4709-14. doi: 10.1074/jbc.M109.041913. Epub 2009 Dec 10. J Biol Chem. 2010. PMID: 20007694 Free PMC article.
-
Growth Hormone, Not IGF-1 Is the Key Longevity Regulator in Mammals.J Gerontol A Biol Sci Med Sci. 2022 Sep 1;77(9):1719-1723. doi: 10.1093/gerona/glac092. J Gerontol A Biol Sci Med Sci. 2022. PMID: 35436323 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources